Healthcare -
Biotechnology - NASDAQ - US
$ 0.6625
-2.17 %
$ 51.8 M
Market Cap
4.14
P/E
CTMX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss CTMX - CytomX Therapeutics, Inc.
95 K
LAST VALUE
54.68%
2 YEAR CAGR
24.75%
5 YEAR CAGR
8.39%
10 YEAR CAGR